Laura Armengol‐Debeir

614 total citations
15 papers, 355 citations indexed

About

Laura Armengol‐Debeir is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Laura Armengol‐Debeir has authored 15 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 7 papers in Surgery and 7 papers in Epidemiology. Recurrent topics in Laura Armengol‐Debeir's work include Inflammatory Bowel Disease (12 papers), Microscopic Colitis (7 papers) and Eosinophilic Esophagitis (4 papers). Laura Armengol‐Debeir is often cited by papers focused on Inflammatory Bowel Disease (12 papers), Microscopic Colitis (7 papers) and Eosinophilic Esophagitis (4 papers). Laura Armengol‐Debeir collaborates with scholars based in France, Italy and Switzerland. Laura Armengol‐Debeir's co-authors include Guillaume Savoye, Laurent Peyrin‐Biroulet, Hélène Sarter, Corinne Gower‐Rousseau, Mathurin Fumery, Benjamin Pariente, Cloé Charpentier, Francis Vasseur, Dominique Turck and Céline Savoye‐Collet and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and Human Reproduction.

In The Last Decade

Laura Armengol‐Debeir

13 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Armengol‐Debeir France 8 272 171 169 43 33 15 355
Ohad Atia Israel 10 221 0.8× 166 1.0× 83 0.5× 36 0.8× 40 1.2× 37 269
Noémie Tavernier France 3 150 0.6× 109 0.6× 86 0.5× 80 1.9× 93 2.8× 3 231
Tobias Klugmann Germany 7 221 0.8× 191 1.1× 105 0.6× 27 0.6× 71 2.2× 15 347
Mette Julsgaard Denmark 12 139 0.5× 68 0.4× 192 1.1× 208 4.8× 284 8.6× 38 404
Antonio López-San Román Spain 11 157 0.6× 166 1.0× 138 0.8× 74 1.7× 116 3.5× 29 368
Giulia D’Arcangelo Italy 10 217 0.8× 165 1.0× 108 0.6× 32 0.7× 19 0.6× 27 279
J E Laberenne France 4 200 0.7× 147 0.9× 120 0.7× 44 1.0× 33 1.0× 6 268
Manar Matar Israel 9 281 1.0× 216 1.3× 105 0.6× 106 2.5× 44 1.3× 35 392
Amit Dhillon Canada 5 211 0.8× 130 0.8× 151 0.9× 59 1.4× 65 2.0× 7 310
E Iglesias-Flores Spain 8 246 0.9× 188 1.1× 131 0.8× 72 1.7× 36 1.1× 23 320

Countries citing papers authored by Laura Armengol‐Debeir

Since Specialization
Citations

This map shows the geographic impact of Laura Armengol‐Debeir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Armengol‐Debeir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Armengol‐Debeir more than expected).

Fields of papers citing papers by Laura Armengol‐Debeir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Armengol‐Debeir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Armengol‐Debeir. The network helps show where Laura Armengol‐Debeir may publish in the future.

Co-authorship network of co-authors of Laura Armengol‐Debeir

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Armengol‐Debeir. A scholar is included among the top collaborators of Laura Armengol‐Debeir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Armengol‐Debeir. Laura Armengol‐Debeir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bourrier, Anne, Maria Nachury, Stéphane Nancey, et al.. (2020). Vedolizumab for perianal Crohn’s disease: a multicentre cohort study in 151 patients. Alimentary Pharmacology & Therapeutics. 51(7). 719–727. 46 indexed citations
2.
Biron, Christine A., Philippe Seksik, Maria Nachury, et al.. (2019). DOP78 Efficacy of vedolizumab in perianal Crohn’s disease: the BioLAP multi-centre observational study. Journal of Crohn s and Colitis. 13(Supplement_1). S077–S077. 3 indexed citations
3.
Ďuricová, Dana, Benjamin Pariente, Hélène Sarter, et al.. (2018). Impact of age at diagnosis on natural history of patients with elderly-onset ulcerative colitis: A French population-based study. Digestive and Liver Disease. 50(9). 903–909. 11 indexed citations
4.
Desprez, Charlotte, Cloé Charpentier, S. Grigioni, et al.. (2018). Deep remission on magnetic resonance imaging impacts outcomes of perianal fistulizing Crohn’s disease. Digestive and Liver Disease. 51(3). 358–363. 23 indexed citations
5.
Ghione, S, Hélène Sarter, Mathurin Fumery, et al.. (2017). Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988–2011): A Population-Based Study of French Adolescents. The American Journal of Gastroenterology. 113(2). 265–272. 109 indexed citations
6.
Armengol‐Debeir, Laura, et al.. (2017). Effectiveness of vedolizumab for Crohn's disease with spondyloarthritis in fail with two TNF blocking agents. Joint Bone Spine. 85(4). 495–496. 2 indexed citations
7.
Armengol‐Debeir, Laura, Cloé Charpentier, Valérie Bridoux, et al.. (2017). Magnetic resonance imaging may predict deep remission in patients with perianal fistulizing Crohn's disease. World Journal of Gastroenterology. 23(23). 4285–4285. 27 indexed citations
8.
Joly, Francisca, Didier Quilliot, Philippe Beau, et al.. (2017). First Study in "Real Life" on the Effect of Teduglutide at 3 Months in a Cohort of Adult Patients with Short Bowel Syndrome (SBS). Transplantation. 101(6S2). S9–S9.
9.
Sarter, Hélène, Mathurin Fumery, Francis Vasseur, et al.. (2016). Incidence and Phenotype at Diagnosis of Very-early-onset Compared with Later-onset Paediatric Inflammatory Bowel Disease: A Population-based Study [1988–2011]. Journal of Crohn s and Colitis. 11(5). jjw194–jjw194. 77 indexed citations
10.
Fumery, Mathurin, Laura Armengol‐Debeir, Hélène Sarter, et al.. (2015). Postoperative Complications in Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 22(1). 127–133. 21 indexed citations
11.
Sarter, Hélène, Mathurin Fuméry, Laura Armengol‐Debeir, et al.. (2015). P121. Delay in diagnosis of Crohn's disease: description over time and identification of associated factors. A 21-year population based study. Journal of Crohn s and Colitis. 9(suppl 1). S137–S137. 1 indexed citations
12.
Ghione, S, Hélène Sarter, Laura Armengol‐Debeir, et al.. (2015). Su1296 Increase of Inflammatory Bowel Disease Incidence in Teenagers in a Prospective Population-Based-Study During a 21-Year Period (1988-2008). Gastroenterology. 148(4). S–465.
13.
Dauchet, Luc, Cloé Charpentier, Mathurin Fuméry, et al.. (2014). DOP094 Cancer in elderly-onset inflammatory bowel disease: A population-based study. Journal of Crohn s and Colitis. 8. S60–S60. 3 indexed citations
14.
Lerebours, Éric, et al.. (2013). Infection liée à la voie veineuse centrale. Prévention et traitement. Nutrition Clinique et Métabolisme. 27(4). 212–217. 2 indexed citations
15.
Armengol‐Debeir, Laura, Guillaume Savoye, Anne‐Marie Leroi, et al.. (2011). Pathophysiological approach to bowel dysfunction after segmental colorectal resection for deep endometriosis infiltrating the rectum: a preliminary study. Human Reproduction. 26(9). 2330–2335. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026